
The Neuberger High Yield Strategies Fund Inc., identified by its symbol NHS, is a closed-end investment vehicle focused on fixed income. Established by Neuberger Berman LLC and overseen by Neuberger Berman Investment Advisers LLC, it allocates capital to debt instruments in global markets. The fund primarily targets high-yield bonds issued by companies across numerous sectors, such as automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution…
Is NHS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2026, has a record date of September 15, 2026, and has an ex-date of September 15, 2026.

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") announced today that its Board of Directors has approved a $25 million increase in the committed debt financing available under its revolving debt financing facility ("Revolving Loan Facility") with a major unaffiliated financial institution, as well as the issuance of $10 million in additional Mandatory Redeemable Preferred Shares, Series D ("Series D Preferred Shares"), in each case subject to completion of documentation and customary closing conditions. The Fund anticipates finalizing the amendment to Revolving Loan Facility and issuing the Series D Preferred Shares within the next week.

NEW YORK, July 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on August 31, 2026, has a record date of August 17, 2026, and has an ex-date of August 17, 2026.

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $6.79 and traded as low as $6.11. Neuberger Berman High Yield Strategies Fund shares last traded at $6.12, with a volume of 68,514 shares.

Ventripoint's VMS+ platform to be evaluated alongside a second AI technology in a landmark NHS study exploring earlier detection of chemotherapy-related heart damage Toronto, Ontario – TheNewswire – July 20, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a leader in the application of artificial intelligence to echocardiography, today announced that its VMS+ technology has been selected for use in AIRES (Artificial Intelligence Reconstruction of Echocardiography Study), a newly launched clinical research study at The Royal Wolverhampton NHS Trust (RWT) in the United Kingdom.